DRUGS REPORTS
oFF-Patents - iagim
oFF-Patents - iagim
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Drugs Off-Patent Reports<br />
% Market Share<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
35<br />
1992<br />
Generic Market Share of Total Rx Business<br />
40 42 43 43 44<br />
47 47.2 48.4 49.1 50.5<br />
1993<br />
1994<br />
1995<br />
1996<br />
1997<br />
1998<br />
1999<br />
2000<br />
2001<br />
2002<br />
Sales Year<br />
8<br />
7<br />
Total $ Sales of Expiring Drugs - Next 10 Years<br />
7.1<br />
7.3<br />
7<br />
6.6<br />
Market Value ($Billions)<br />
6<br />
5<br />
4<br />
3<br />
2<br />
1<br />
1.1<br />
3.6<br />
3.1<br />
3.8<br />
2.8<br />
4<br />
2<br />
3.2<br />
1.6<br />
0<br />
1998<br />
1999<br />
2000<br />
2001<br />
2002<br />
2003<br />
2004<br />
2005<br />
2006<br />
2007<br />
2008<br />
2009<br />
2010<br />
Expiration Year<br />
Argentinia<br />
3.4<br />
World Retail Rx Sales - $216.3 ($ Billions)<br />
Cardiovascular products<br />
amount to $42 billion of total<br />
Mexico<br />
Brazil<br />
S America<br />
4.6<br />
5.1<br />
13.1<br />
Fastest growing segment<br />
musculoskeletal - $12 billion<br />
Spain<br />
5.5<br />
REGION<br />
UK<br />
Italy<br />
France<br />
9.2<br />
9.3<br />
13.8<br />
Germany<br />
Europe<br />
14.9<br />
52.7<br />
Retail Rx sales in Europe<br />
and Japan almost equal<br />
Japan<br />
51.7<br />
North Am.<br />
98.9<br />
Canada<br />
5.3<br />
US<br />
94<br />
0 10 20 30 40 50 60 70 80 90 100<br />
Rx Market Value - Key Markets<br />
Drugs Off-Patent Reports 25 Over USD$ 100 million
Change language